EquityZen Growth Technology Fund LLC - Series 2027
Raised
$156K
Investors
14
Min Invest
$10,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2027 is a Delaware-based pooled investment vehicle filed by EquityZen Advisors and Philip Haslett, raising $156K from 14 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is part of EquityZen's pre-IPO platform, which operates 1,889 related EDGAR entities providing access to private company secondary market positions.
This pre-IPO vehicle follows the standard EquityZen series structure with a retail-accessible $10K minimum investment and Rule 506(b) private placement exemption. The offering size and investor count are consistent with a single-company SPV targeting narrow participation in a specific private company's shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
